The World Health Organization declared on Wednesday that it will resume clinical trials of the drug hydroxychloroquine as a coronavirus treatment.
“On the basis of the available mortality data, the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO chief Tedros Adhanom Ghebreyesus said during a virtual briefing. The WHO suspended trials of the antimalaria drug last week.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
